AbbVie
ABBV
$241.56
Share price
2.37%
Change (1 day)
5.58%
Change (1 year)
Categories
The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol “ABBV”.
Earnings for AbbVie (ABBV)
Earnings in 2024 (TTM): S$4.86 Billion
According to AbbVie's latest financial reports the company's current earnings are S$56.33 Billion. a decrease over its 2023 earnings that were of S$8.39 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for AbbVie from 2011 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024  | S$4.99 B | -40.54% |
| 2023 | S$8.39 B | -53.62% |
| 2022 | S$18.10 B | 3.76% |
| 2021 | S$17.44 B | 282.25% |
| 2020 | S$4.56 B | -59.67% |
| 2019 | S$11.31 B | 62.13% |
| 2018 | S$6.98 B | -32.74% |
| 2017 | S$10.37 B | -1.99% |
| 2016 | S$10.58 B | 18.65% |
| 2015 | S$8.92 B | 180.5% |
| 2014 | S$3.18 B | -55.57% |
| 2013 | S$7.16 B | -6.86% |
| 2012 | S$7.68 B | 56.05% |
| 2011 | S$4.92 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | S$14.92 B | 199.06% | 🇺🇸 USA |
 | -S$11.26 Billion | -325.48% | 🇺🇸 USA |
 | S$17.03 B | 241.24% | 🇺🇸 USA |
 | S$6.19 B | 24.03% | 🇺🇸 USA |
 | S$0.92 B | -81.43% | 🇺🇸 USA |
 | S$2.56 B | -48.71% | 🇺🇸 USA |
 | S$5.90 B | 18.26% | 🇬🇧 UK |
 | S$14.01 B | 180.76% | 🇬🇧 UK |
 | S$0.68 B | -86.19% | 🇺🇸 USA |